The corresponding “road map,” which will be presented by the administration, includes recommendations for ministries and departments to coordinate efforts if necessary to make appropriate legislative changes, WSJ notes.
The administration of U.S. President Joe Biden intends to seek to reduce the prices of prescription drugs, which is intended to contribute to the plan developed by it, The Wall Street Journal reported on Thursday.
The White House plans to promote the adoption of a bill aimed at the same, and the developed plan, which will be presented on Thursday, will be, as the newspaper writes, the first “road map” of the administration’s actions in support of efforts to reduce prices for medical drugs.
As the newspaper has learned, the plan proposes, in addition to supporting the bill developed by Democratic lawmakers, to give federal authorities the authority to discuss drug pricing under the national Medicare health insurance program and the ability to reduce the cost of drugs also in the private medical sector. The” road map,” the publication says, also includes recommendations for ministries and departments to coordinate efforts if necessary to make appropriate legislative changes.
“The Biden-Harris administration remains committed to making access to medical care as open as possible for American families, and this plan represents the main route we will follow to achieve this, “the Wall Street Journal quotes the statement of the U.S. Secretary of Health and Human Services Xavier Becerra. “By promoting negotiations, competition, and innovation in the healthcare sector, we will strive to establish fair prices and defend access to medical care.”